{
    "clinical_study": {
        "@rank": "63756", 
        "acronym": "VRK", 
        "arm_group": [
            {
                "arm_group_label": "VR during burn care with Ketamine", 
                "arm_group_type": "Experimental", 
                "description": "Comparing Virtual Reality during burn care with Ketamine"
            }, 
            {
                "arm_group_label": "VR durin burn care without Ketamine", 
                "arm_group_type": "No Intervention", 
                "description": "Comparing virtual reality during burn care without Ketamine."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the research is to see whether a low dose of ketamine, a medication used to\n      reduce pain, enhances the effectiveness of a virtual reality video game, which is used as a\n      form of distraction from pain during a painful burn care procedure."
        }, 
        "brief_title": "Low Dose Ketamine VR Analgesia During Burn Care Procedure", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Burn", 
        "condition_browse": {
            "mesh_term": "Burns"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age greater than or equal to 18 years\n\n          -  Compliant and able to complete questionnaires\n\n          -  No history of psychiatric disorder\n\n          -  Not demonstrating delirium, psychosis or any form of Organic Brain Disorder\n\n          -  Able to communicate verbally\n\n          -  English-speaking\n\n          -  IV access already in place\n\n        Exclusion Criteria:\n\n          -  Age less than 18 years\n\n          -  Not capable of indicating pain intensity\n\n          -  Not capable of filling out study measures\n\n          -  Evidence of traumatic brain injury\n\n          -  History of psychiatric disorder\n\n          -  Demonstrating delirium, psychosis or any form of Organic Brain Disorder and\n             associated memory problems\n\n          -  Unable to communicate orally\n\n          -  Receiving prophylaxis for alcohol or drug withdrawal\n\n          -  Developmental disability\n\n          -  Any face/head/neck injuries that interfere with the use of Virtual Reality equipment\n\n          -  Non-English Speaking\n\n          -  Extreme susceptibility to motion sickness\n\n          -  Seizure history\n\n          -  No IV access already in place"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01889537", 
            "org_study_id": "43329-K"
        }, 
        "intervention": {
            "arm_group_label": "VR during burn care with Ketamine", 
            "intervention_name": "Virtual Reality", 
            "intervention_type": "Behavioral"
        }, 
        "intervention_browse": {
            "mesh_term": "Ketamine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Virtual Reality Ketamine", 
        "lastchanged_date": "September 30, 2013", 
        "location": {
            "contact": {
                "email": "davepatt@uw.edu", 
                "last_name": "David Patterson, PH.D.", 
                "phone": "206-744-3418"
            }, 
            "facility": {
                "address": {
                    "city": "Seattle", 
                    "country": "United States", 
                    "state": "Washington", 
                    "zip": "98104"
                }, 
                "name": "Harborview Medical Center"
            }, 
            "investigator": {
                "last_name": "David Patterson, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Low Dose Ketamine to Enhance VR Analgesia During Painful Burn Care Procedure.", 
        "overall_contact": {
            "email": "davepatt@uw.edu", 
            "last_name": "David R Patterson, Ph.D.", 
            "phone": "206-744-5443"
        }, 
        "overall_contact_backup": {
            "email": "soltani@uw.edu", 
            "last_name": "Maryam Soltani, M.Ed.", 
            "phone": "206-744-2172"
        }, 
        "overall_official": {
            "affiliation": "University of Washington", 
            "last_name": "David R Patterson, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Graphic Rating Scale (GRS) is a questionnaire consists of three subjective pain ratings, one subjective anxiety rating, and one rating of fun using the 0-10.", 
            "safety_issue": "No", 
            "time_frame": "1 day (Immediately following burn care )"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01889537"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National Institute of General Medical Sciences (NIGMS)", 
            "investigator_full_name": "David R. Patterson", 
            "investigator_title": "PhD. ABPP, Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "National Institute of General Medical Sciences (NIGMS)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of General Medical Sciences (NIGMS)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}